Hendra vaccine a step closer

A year-long trial of a Hendra vaccine on people has ended, with none of the 40 participants reporting any major complications.

The trial consisted of five groups of eight people aged between 18 and 65 and wrapped up a couple of weeks ago.

Six people were given the monoclonal antibody and two received a placebo.


Chief Health Officer and Deputy Director-General Prevention Division Jeannette Young confirmed everyone who took part was fine and none reported any serious adverse events.

The Department is in the processes of analysing the data collected during the clinical trial.  The results are due back towards the end of the year.

Several Gold and Tweed Coast horses died from the Hendra Virus in 2011 and 2015.